[{"data":1,"prerenderedAt":26},["ShallowReactive",2],{"$fKunv6FahJdcxceEEqoNJE27kwW_KEIpbg6apWpLb__U":3},{"card":4,"examId":6,"chapterTitle":23,"prev":24,"next":25},{"id":5,"examId":6,"prompt":7,"answer":8,"choices":9,"questionType":12,"explanation":13,"explanationDetail":14,"mistakeHint":15,"lectureRef":15,"storyRef":15,"chapterSlug":16,"sectionCode":17,"sectionTitle":18,"clusterSlug":19,"term":15,"sequenceOrder":20,"regionWeight":15,"revisionMark":21,"isActive":22},"ch4-107","touhan","指定濫用防止医薬品は外用剤も含めて全ての剤形が指定対象となる。",1,[10,11],"正しい","誤り","ox","指定成分は「ただし、外用剤を除く」とされており、外用剤は指定対象から除外されます。","外用剤の範囲は、口腔用錠剤(トローチ剤、バッカル錠等)、吸入剤、点眼剤、点耳剤、点鼻剤、坐剤、膣錠、軟膏剤・貼付剤等を指します。これらに分類される剤形は指定濫用防止医薬品に該当しません。",null,"chapter-4","4-II-2","リスク区分に応じた販売方法・特定販売","shitei-ranyou-boushi",107,"令和8年4月一部改訂",true,"第4章 薬事関係法規・制度","ch4-106","ch4-108",1784619074402]